We are live on
!
Find out more
BioMarin Pharmaceuticals
BMRN
BMRN
584 hedge funds and large institutions have $13.1B invested in BioMarin Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 100 funds opening new positions, 244 increasing their positions, 175 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 542 → 584 (+42)
1.63% more ownership
Funds ownership: 96.17% → 97.8% (+1.6%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
584
Holding in Top 10
6
Calls
$97.7M
Puts
$87.7M
Top Buyers
| 1 | +$110M | |
| 2 | +$108M | |
| 3 | +$81.2M | |
| 4 |
Goldman Sachs
New York
|
+$72.9M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$56.3M |
Top Sellers
| 1 | -$258M | |
| 2 | -$96.1M | |
| 3 | -$68.7M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$56.5M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$44.8M |